DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Ausgabe S 05 · Volume 107 · 1999 DOI: 10.1055/s-002-19251

A - Pathogenesis of TAO

  • S149
    Weetman, A. P.; Hunt, P. J.:

    The immunogenetics of thyroid-associated orbitopathy

  • S152
    Heufelder, A. E.; Joba, W.:

    Cellular immunity and orbital antigens in thyroid-associated orbitopathy

  • S158
    Ludgate, M.:

    Animal model of thyroid-associated orbitopathy

  • S160
    Smith, T. J.:

    The putative role of prostaglandin endoperoxide H synthase-2 in the pathogenesis of thyroid-associated orbitopathy

    • B - Risk factors and TAO

  • S164
    Mann, K.:

    Risk of smoking in thyroid-associated orbitopathy

  • S168
    Egle, U. T.; Kahaly, G. J.; Petrak, F.; Hardt, J.; Batke, J.; Best, J.; Rothenbacher, M.:

    The relevance of physical and psychosocial factors for the quality of life in patients with thyroid-associated orbitopathy (TAO)

    • C - Diagnostic procedures in TAO

  • S172
    Grüters, A.:

    Ocular manifestations in children and adolescents with thyrotoxicosis

  • S175
    Guthoff, R.; Schittkowski, M.:

    Ophthalmic management of thyroid-associated orbitopathy

  • S177
    Müller-Forell, W.; Pitz, S.; Mann, W.; Kahaly, G. J.:

    Neuroradiological diagnosis in thyroid-associated orbitopathy

  • S184
    Bockisch, A.; Kahaly, G. J.; Görges, R.:

    111In-pentetreotide scintigraphy in thyroid-associated orbitopathy

    • D - Thyroid treatment and TAO

  • S186
    Benker, G.; Kahaly, G. J.; Reinwein, D.; and the European Multicenter Trial Group:

    What can the European Multicenter Trial on the treatment of Graves' disease with antithyroid drugs teach us about the course of thyroid-associated orbitopathy (TAO)?

  • S190
    Dietlein, M.; Dederichs, B.; Weigand, A.; Schicha, H.:

    Radioiodine therapy and thyroid-associated orbitopathy: risk factors and preventive effects of glucocorticoids

  • S195
    Dralle, H.:

    Current status of total thyroidectomy in thyroid-associated orbitopathy

    • E - Therapy of TAO

  • S198
    Prummel, M. F.:

    Medical treatment of thyroid-associated orbitopathy

  • S201
    Kahaly, G. J.; Roesler, H. P.; Kutzner, J.; Pitz, S.; Müller-Forell, W.; Beyer, J.; Mann, W.:

    Radiotherapy for thyroid-associated orbitopathy

  • S208
    Olivari, N.:

    Thyroid-associated orbitopathy: Transpalpebral decompression by removal of intraorbital fat

  • S212
    Mann, W. J.; Kahaly, G. J.; Pitz, S.; Bumb, P.; Müller-Forell, W.; Krummenauer, F.; Goerzen, N.; Mewes, T.; Pfeiffer, N.:

    Decompression surgery for thyroid-associated orbitopathy — a ten year experience

  • S214
    Esser, J.; Eckstein, Anja:

    Ocular muscle and eyelid surgery in thyroid-associated orbitopathy